histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration drosophila 
proteins expanded polyglutamine repeats cause huntingtons disease neurodegenerative diseases transcriptional dysregulation loss function transcriptional coactivator proteins implicated pathogenesis diseases1 huntingtons disease caused expansion repeated sequence amino acid glutamine abnormal protein huntingtin htt show polyglutamine-containing domain htt htt exon protein httex1p directly binds acetyltransferase domains two distinct proteins: creb-binding protein cbp p300/cbp-associated factor p/caf cell-free assays httex1p also inhibits acetyltransferase activity least three enzymes: p300 p/caf cbp expression httex1p cultured cells reduces level acetylated histones h3 h4 reduction can reversed administering inhibitors histone deacetylase hdac vivo hdac inhibitors arrest ongoing progressive neuronal degeneration induced polyglutamine repeat expansion reduce lethality two drosophila models polyglutamine disease findings raise possibility therapy hdac inhibitors may slow prevent progressive neurodegeneration seen huntingtons disease polyglutamine-repeat diseases even onset symptoms 
